7.85Open6.50Pre Close2 Volume51 Open Interest72.00Strike Price1.56KTurnover63.17%IV0.71%PremiumDec 6, 2024Expiry Date7.14Intrinsic Value100Multiplier4DDays to Expiry0.56Extrinsic Value100Contract SizeAmericanOptions Type0.9270Delta0.0264Gamma10.84Leverage Ratio-0.0913Theta0.0073Rho10.05Eff Leverage0.0115Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet